GB202207246D0 - PCSK9 antagonist - Google Patents

PCSK9 antagonist

Info

Publication number
GB202207246D0
GB202207246D0 GBGB2207246.6A GB202207246A GB202207246D0 GB 202207246 D0 GB202207246 D0 GB 202207246D0 GB 202207246 A GB202207246 A GB 202207246A GB 202207246 D0 GB202207246 D0 GB 202207246D0
Authority
GB
United Kingdom
Prior art keywords
pcsk9 antagonist
pcsk9
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2207246.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argonaute RNA Ltd
Original Assignee
Argonaute RNA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argonaute RNA Ltd filed Critical Argonaute RNA Ltd
Priority to GBGB2207246.6A priority Critical patent/GB202207246D0/en
Publication of GB202207246D0 publication Critical patent/GB202207246D0/en
Priority to GB2306581.6A priority patent/GB2618915A/en
Ceased legal-status Critical Current

Links

GBGB2207246.6A 2022-05-18 2022-05-18 PCSK9 antagonist Ceased GB202207246D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2207246.6A GB202207246D0 (en) 2022-05-18 2022-05-18 PCSK9 antagonist
GB2306581.6A GB2618915A (en) 2022-05-18 2023-05-04 Treatment of cardiovascular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2207246.6A GB202207246D0 (en) 2022-05-18 2022-05-18 PCSK9 antagonist

Publications (1)

Publication Number Publication Date
GB202207246D0 true GB202207246D0 (en) 2022-06-29

Family

ID=82155981

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2207246.6A Ceased GB202207246D0 (en) 2022-05-18 2022-05-18 PCSK9 antagonist

Country Status (1)

Country Link
GB (1) GB202207246D0 (en)

Similar Documents

Publication Publication Date Title
IL279363A (en) Pcsk9 antagonist compounds
GB2594788B (en) Antagonist of PCSK9
IL304534A (en) Kras g12c inhibitors
EP3810129A4 (en) Pcsk9 antagonist bicyclo-compounds
EP4076492A4 (en) Pcsk9 antagonist compounds
GB2585278B (en) Apolipoprotein B Antagonist
IL300211A (en) Antagonist compounds
CA199777S (en) Bowl
GB202019622D0 (en) Antagonist compounds
CA198610S (en) Bowl
GB202207246D0 (en) PCSK9 antagonist
EP4317153A4 (en) Abhd6 antagonist
GB202010276D0 (en) PCSK9 antagonist
GB202113104D0 (en) Antagonist of pcsk9
GB202020553D0 (en) Antagonist of pcsk9
GB202013998D0 (en) Antagonist of pcsk9
GB202003756D0 (en) Antagonist of PCSK9
GB202000906D0 (en) Antagonist
GB202217505D0 (en) Selective beta2-adrencoceptor antagonist
GB202201151D0 (en) Antagonist compounds
CA219625S (en) Bowl
CA216344S (en) Bowl
CA216346S (en) Bowl
CA216355S (en) Bowl
CA198153S (en) Bowl

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)